Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;14(5):883-895.
doi: 10.1007/s40123-025-01115-0. Epub 2025 Mar 29.

Parainflammation in the Ocular System: Considerations on the Underlying Mechanisms and Treatment of Dry Eye Disease

Affiliations
Review

Parainflammation in the Ocular System: Considerations on the Underlying Mechanisms and Treatment of Dry Eye Disease

Stefano Barabino et al. Ophthalmol Ther. 2025 May.

Abstract

Introduction: The transition from regulated to dysregulated parainflammation is a new concept that needs to be elucidated to clarify the pathogenesis of dry eye disease (DED). This review summarizes the recent evidence about mechanisms that could lead to dysregulated parainflammation, proposing a new hypothesis to correlate this process with the progression to chronic inflammation.

Methods: A group of European experts on DED participated in a roundtable to discuss the role of parainflammation in the most common ocular diseases with regard to DED. Starting from the roundtable contents, a narrative review was conducted through a PubMed search based on the main topics discussed, namely: parainflammation, dysfunctional parainflammation, tear film lipid and mucin alterations, and tear cortisol.

Results: Parainflammation is involved in different ocular pathologies and is characterized by the involvement of the immune system and complement factors. In DED, continuous and persistent insults are responsible for the qualitative and quantitative alteration of the lipid and mucin components of the tear film. In addition, other contributing factors have recently been described, such as the reduction of cortisol synthesis by corneal epithelial cells. This altered condition leads to excessive macrophage activity, releasing cytokines and adhesion molecules, losing tissue homeostasis, and possibly progressing to chronic inflammation.

Conclusions: Literature evidence supports the crucial role of parainflammation and its usefulness in improving the diagnosis and treatment of DED. At the same time, further investigations are necessary to better define the transition from functional to dysfunctional parainflammation, including the role of ocular surface components other than the tear film.

Keywords: Cortisol; Dry eye disease; Dysfunctional parainflammation; Lipids; Mucins; Ocular system; Parainflammation.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: Pasquale Aragona: Consultant for AbbVie, Alcon, Alfa Intes, Bausch and Lomb, DMG, FB Vision, Fidia, Santen, SIFI, Thea, TRB-Chemedica. Stefano Barabino: consultant for Fidia, TRB-Chemedica, Alfa Intes, Alcon. Christophe Baudouin: consultant for Alcon, Glaukos, Horus Pharma, Oculis, Santen, Thea. Elisabeth M. Messmer: speaker for: Alcon/Novartis, Bausch & Lomb, Dompé, Novartis, Santen GmbH, Théa Pharma GmbH, TRB-Chemedica AG, Visufarma. Consultant for: Alcon/Novartis, Alfa Intes, DMG, Dompé, Kala, Novartis, Santen GmbH, Shire, Sun, Sifi, Théa Pharma GmbH, TRB-Chemedica AG, Visufarma. José M. Benítez-del-Castillo: consultant for Brill, GSK, Santen, Sifi, Thea, Viatris. Jutta Horwath-Winter: Speaker or consultant for: Alfa Intes, Bausch & Lomb, Icom Medical, Laboratoires Thea, Mc2 Therapeutics, Santen, Shire, TRB-Chemedica, Ursapharm. Edward Wylegala: speaker for Alcon, Baush & Lomb, Thea Santen; consultant for: Optopol Technology. Kostas Boboridis, José Salgado-Borges, Adriana Stanila and Maurizio Rolando have nothing to disclose. Ethical Approval: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Figures

Fig. 1
Fig. 1
Schematic representation depicting parainflammation as an intermediate state between homeostasis and chronic inflammation
Fig. 2
Fig. 2
Progression of ocular para-inflammation over time. Functional para-inflammation maintains homeostasis through increased tear production, blinking rate, mucin secretion, and epithelial turnover. As compensatory mechanisms fail, dysfunctional para-inflammation leads to elevated pro-inflammatory agents, reduced mucin and tear production, and decreased cold receptor sensitivity, resulting in a progressive loss of ocular surface homeostasis

Similar articles

References

    1. Gipson IK. The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2007;48(4390):4391–8. - PMC - PubMed
    1. Stern ME, Gao J, Siemasko KF, et al. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78:409–16. - PubMed
    1. Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;11:246–58. - PubMed
    1. Rolando M, Barabino S. The subtle role of para-inflammation in modulating the progression of dry eye disease. Ocul Immunol Inflamm. 2021;29:811–6. - PubMed
    1. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocular Surf. 2017;15:334–65. - PubMed

LinkOut - more resources